2. Gene
  3. AKT2 - AKT serine/threonine kinase 2 Gene

AKT2 - AKT serine/threonine kinase 2 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：AKT 丝氨酸/苏氨酸激酶 2

种属: Macaca fascicularis

基因 ID: 102132744 | 基因类型: protein coding

关于 AKT2

Primary_assembly 19: 39,587,151-39,702,948 reverse strand.Macaca_fascicularis_6.0:CM021957.1

This gene has 8 transcripts (splice variants), 237 orthologues and 5 paralogues.

AKT2 基因产物(7)

mRNA Protein Name
XM_015441281.2 XP_015296767.1 RAC-beta serine/threonine-protein kinase isoform X1
XM_045380201.1 XP_045236136.1 RAC-beta serine/threonine-protein kinase isoform X1
XM_005589250.3 XP_005589307.1 RAC-beta serine/threonine-protein kinase isoform X1
XM_005589248.3 XP_005589305.1 RAC-beta serine/threonine-protein kinase isoform X1
XM_045380204.1 XP_045236139.1 RAC-beta serine/threonine-protein kinase isoform X2
XM_045380203.1 XP_045236138.1 RAC-beta serine/threonine-protein kinase isoform X1
XM_015441282.2 XP_015296768.1 RAC-beta serine/threonine-protein kinase isoform X1

AKT2 蛋白结构

PH_PKB

PH_PKB: cd01241 (3 - 110)

STKc_PKB_beta

STKc_PKB_beta: cd05595 (155 - 477)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 481 a.a.
蛋白主名 其他名称

RAC-beta serine/threonine-protein kinase

相关产品

Clinical Phase
生物活性分子 (18)
目录号 产品名 作用方式
纯度 Phase
HY-15186 Ipatasertib Inhibitor 99.88% Phase 4
HY-N0004 Oridonin Inhibitor 99.89% Phase 4
HY-15186A Ipatasertib dihydrochloride Inhibitor 99.27% Phase 4
HY-15431 Capivasertib Inhibitor 99.95% Phase 3
HY-10358 MK-2206 dihydrochloride Inhibitor 99.99% Phase 2
HY-19719 Miransertib Inhibitor 99.32% Phase 2
HY-15727 Afuresertib Inhibitor 99.54% Phase 2
HY-15965 Uprosertib Inhibitor 99.74% Phase 2
HY-15727A Afuresertib hydrochloride Inhibitor 99.95% Phase 2
HY-19934A Pifusertib hydrochloride Inhibitor 98.96% Phase 2
HY-19719A Miransertib hydrochloride Inhibitor 99.74% Phase 2
HY-19934 Pifusertib Inhibitor / Phase 2
HY-108232 MK-2206 Inhibitor / Phase 2
HY-15965A Uprosertib hydrochloride Inhibitor / Phase 2
HY-10249 GSK-690693 Inhibitor 98.46% Phase 1
HY-100018 BAY1125976 Inhibitor 99.74% Phase 1
HY-16071 AT13148 Inhibitor 99.21% Phase 1
HY-137458 Vevorisertib Inhibitor / Phase 1
Pre-clinical Phase
生物活性分子 (26)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-10355 AKT inhibitor VIII Inhibitor 98.97% 否
HY-10425 A-443654 Inhibitor 98.50% 否
HY-137458A Vevorisertib trihydrochloride Inhibitor 99.13% 否
HY-12059 AT7867 Inhibitor 99.88% 否
HY-133120 INY-03-041 Inhibitor 99.74% 否
HY-13260 CCT128930 Inhibitor 99.69% 否
HY-151504 ALM301 Inhibitor 99.33% 否
HY-12059A AT7867 dihydrochloride Inhibitor 99.75% 否
HY-145282 MS170 Inhibitor 99.72% 否
HY-16666 3CAI Inhibitor 99.97% 否
HY-19982 AKT-IN-6 Inhibitor 99.51% 否
HY-50862 Akt1/Akt2-IN-1 Inhibitor 99.59% 否
HY-13260A CCT128930 hydrochloride Inhibitor 98.32% 否
HY-126257 AKT-IN-3 Inhibitor 99.29% 否
HY-133120A INY-03-041 trihydrochloride Inhibitor 99.27% 否
HY-151613 MS15 Inhibitor / 否
HY-145281 MS98 Inhibitor / 否
HY-147935 NTQ1062 Inhibitor / 否
HY-132302 Hu7691 Inhibitor / 否
HY-10357 MK-2206 free base Inhibitor / 否
HY-132302A Hu7691 free base Inhibitor / 否
HY-138767 AKT-IN-5 Inhibitor / 否
HY-129119 Akt1/Akt2-IN-2 Inhibitor 98.57% 否
HY-147937 AKT-IN-13 Inhibitor / 否
HY-143611 AKT-IN-8 Inhibitor / 否
HY-16032 Akt1-IN-2 Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens AKT2 NCBI NCBI:208
Mus musculus AKT2 NCBI NCBI:11652
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z